DNAprint Genomics (DNAG)

[SlopsterSlasher]

New York University
DNAprint genomics is engaged in a partnership with the New York University School of Medicine to develop pharmacogenomic classifiers for organ transplant patients.

The goal of the project is to identify pharmacogenomic classifiers that could be used to match renal transplantation patients with the optimal immunosuppressant for their genetic architecture. The project is expected to take about one year to complete, and the results are expected to extend to patients for a wide range of transplantation procedures.

About NYU's Transplant Program:

The Mary Lea Johnson Richards Organ Transplantation Center is one of the busiest and most successful transplant programs in the United States. The program offers transplantation of the liver, kidney and pancreas and performs about 150 transplants annually. Over 500 liver and 200 kidney transplants have been done since program inception and the programs graft and patient survival rates are consistently among the best in the country.